Sun Philip, Markovic Daniela, Ibish Abdullah, Faigle Roland, Gottesman Rebecca, Towfighi Amytis
Department of Neurology, David Geffen School of Medicine at University of California - Los Angeles, Los Angeles, CA.
Keck School of Medicine of University of Southern California, Los Angeles, CA.
medRxiv. 2023 Oct 22:2023.10.20.23297343. doi: 10.1101/2023.10.20.23297343.
Stroke mortality has declined, with differential changes by race; stroke is now the 5th leading cause of death overall, but 2nd leading cause of death in Black individuals. Little is known about recent race/ethnic and sex trends in in-hospital mortality after acute ischemic stroke (AIS) and whether system-level factors contribute to possible differences.
Using the National Inpatient Sample, adults (≥18 years) with a primary diagnosis of AIS from 2006 to 2017 (n=643,912) were identified. We assessed in-hospital mortality by race/ethnicity (White, Black, Hispanic, Asian/Pacific Islander [API], other), sex, and age. Hospitals were categorized by proportion of non-White patients served: <25% ("predominantly White patients"), 25-50% ("mixed race/ethnicity profile"), and ≥50% ("predominantly non-White patients"). Using survey adjusted logistic regression, the association between race/ethnicity and odds of mortality was assessed, adjusting for key sociodemographic, clinical, and hospital characteristics (e.g., age, comorbidities, stroke severity, do not resuscitate orders, and palliative care).
Overall, mortality decreased from 5.0% in 2006 to 2.9% in 2017 (p<0.001). Comparing 2012-2017 to 2006-2011, there was a 68% reduction in mortality odds overall after adjusting for covariates, most prominent in White individuals (69%) and smallest in Black individuals (57%). Compared to White patients, Black and Hispanic patients had lower odds of mortality (adjusted odds ratio (aOR) 0.82, 95% CI 0.78-0.87 and aOR 0.93, 95% CI 0.87-1.00), primarily driven by those >65 years (age x ethnicity interaction p < 0.0001). Compared to White men, Black, Hispanic, and API men, and Black women had lower aOR of mortality. The differences in mortality between White and non-White patients were most pronounced in hospitals predominantly serving White patients (aOR 0.80, 0.74-0.87) compared to mixed hospitals (aOR 0.85, 0.79-0.91) and predominantly non-White hospitals (aOR 0.88, 0.81-0.95; interaction effect: p=0.005).
AIS mortality decreased dramatically in recent years in all race/ethnic subgroups. Overall, non-White AIS patients had lower mortality than their White counterparts, a difference that was most striking in hospitals predominantly serving White patients. Further study is needed to understand these differences and to what extent biological, sociocultural, and system-level factors play a role.
卒中死亡率有所下降,且不同种族的变化存在差异;卒中目前是总体第五大死因,但在黑人个体中是第二大死因。关于急性缺血性卒中(AIS)后住院死亡率的近期种族/民族及性别趋势,以及系统层面因素是否导致了可能存在的差异,我们了解甚少。
利用全国住院患者样本,确定了2006年至2017年期间主要诊断为AIS的成年人(≥18岁)(n = 643,912)。我们按种族/民族(白人、黑人、西班牙裔、亚裔/太平洋岛民[API]、其他)、性别和年龄评估住院死亡率。医院按所服务的非白人患者比例分类:<25%(“主要为白人患者”)、25 - 50%(“混合种族/民族分布”)和≥50%(“主要为非白人患者”)。使用调查调整后的逻辑回归,评估种族/民族与死亡几率之间的关联,并对关键的社会人口学、临床和医院特征(如年龄、合并症、卒中严重程度、不要复苏医嘱和姑息治疗)进行调整。
总体而言,死亡率从2006年的5.0%降至2017年的2.9%(p<0.001)。将2012 - 2017年与2006 - 2011年进行比较,在对协变量进行调整后,总体死亡几率降低了68%,在白人个体中最为显著(69%),在黑人个体中最小(57%)。与白人患者相比,黑人和西班牙裔患者的死亡几率较低(调整后的优势比[aOR]为0.82,95%置信区间[CI]为0.78 - 0.87;aOR为0.93,95% CI为0.87 - 1.00),主要由65岁以上人群驱动(年龄×种族交互作用p < 0.0001)。与白人男性相比,黑人、西班牙裔和API男性以及黑人女性的aOR较低。与混合医院(aOR为0.85,0.79 - 0.91)和主要为非白人的医院(aOR为0.88;0.81 - 0.95;交互作用效应:p = 0.005)相比,白人患者与非白人患者之间的死亡率差异在主要服务白人患者的医院中最为明显(aOR为0.80,0.74 - 0.87)。
近年来,所有种族/民族亚组的AIS死亡率均显著下降。总体而言,非白人AIS患者的死亡率低于白人患者,这种差异在主要服务白人患者的医院中最为显著。需要进一步研究以了解这些差异以及生物学、社会文化和系统层面因素在多大程度上起作用。